Inhibition of HIV-1 Integrase by â-Diketo Acids
Journal of Medicinal Chemistry, 2006, Vol. 49, No. 14 4259
(14) Engelman, A.; Mizuuchi, K.; Craigie, R. HIV-1 DNA integration:
mechanism of viral DNA cleavage and DNA strand transfer. Cell
1991, 67, 1211-1221.
(39) Pais, G. C. G.; Zhang, X.; Marchand, C.; Neamati, N.; Cowansage,
K.; Svarovskaia, E. S.; Pathak, V. K.; Tang, Y.; Nicklaus, M.;
Pommier, Y.; Burke, T. R., Jr. Structure activity of 3-aryl-1,3-diketo-
containing compounds as HIV-1 integrase inhibitors. J. Med. Chem.
2002, 45, 3184-3194.
(40) Marchand, C.; Zhang, X.; Pais, G. C. G.; Cowansage, K.; Neamati,
N.; Burke, T. R., Jr.; Pommier, Y. Structural determinants for HIV-1
integrase inhibition by â-diketo acids. J. Biol. Chem. 2002, 277,
12596-12603.
(41) Sechi, M.; Derudas, M.; Dallocchio, R.; Dessi, A.; Bacchi, A.; Sannia,
L.; Carta, F.; Palomba, M.; Ragab, O.; Chan, C.; Shoemaker, R.;
Sei, S.; Dayam, R.; Neamati, N. Design and synthesis of novel indole
â-diketo acid derivatives as HIV-1 integrase inhibitors. J. Med. Chem.
2004, 47, 5298-5310.
(42) Espeseth, A. S.; Felock, P.; Wolfe, A. Witmer, M.; Grobler, J.;
Anthony, N.; Egbertson, M.; Melamed, J. Y.; Young, S.; Hamill,
T.; Cole, J. L.; Hazuda D. J. HIV-1 integrase inhibitors that compete
with the target DNA substrate define a unique strand transfer
conformation for integrase. Proc. Natl. Acad. Sci. U.S.A. 2000, 97,
11244-11249.
(15) Brown, P. O. Integration; Cold Spring Harbor Press: Cold Spring
Harbor, NY, 1999.
(16) Asante-Appiah, E.; Skalka, A. M. HIV-1 integrase: structural
organization, conformational changes, and catalysis. AdV. Virus Res.
1999, 52, 351-369.
(17) Steitz, T. A. A mechanism for all polymerases. Nature 1998, 391,
231-232.
(18) Dyda, F.; Hickman, A. B.; Jenkins, T. M.; Engelman, A.; Craigie,
R.; Davies, D. R. Crystal structure of the catalytic domain of HIV-1
integrase: similarity to other polynucleotidyl transferases. Science
1994, 266, 1981-1986.
(19) Rice, P. A.; Baker, T. A. Comparative architecture of transposase
and integrase complexes. Nat. Struct. Biol. 2001, 8, 302-307.
(20) Esposito, D.; Craigie, R. HIV integrase structure and function. AdV.
Virus Res. 1999, 52, 319-333.
(21) Chiu, T. K.; Davies, D. R. Structure and function of HIV-1 integrase.
Curr. Top. Med. Chem. 2004, 4, 671-686.
(22) Steitz, T. A. DNA polymerases: structural diversity and common
mechanism. J. Biol. Chem. 1999, 274, 17395-17398.
(43) Yoshinaga, T. S.; Fujishita, T.; Fujiwara, T. In vitro activity of a
new HIV-1 integrase inhibitor in clinical development. Presented at
the 9th Conference on Retroviruses and Opportunistic Infections,
Seattle, WA, 2002.
(23) Horton, N. C., Perona, J. J. Making the most of metal ions. Nat.
Struct. Biol. 2001, 8, 290-293.
(24) Feng, M.; Patel, D.; Dervan, J. J.; Ceska, T.; Suck, D.; Haq, I.; Sayers,
J. R. Roles of divalent metal ions in flap endonuclease-substrate
interactions. Nat. Struct. Biol. 2004, 11, 450-456.
(44) Billich, A. S-1360 Shionogi-GlaxoSmithKline. Curr. Opin. InVest.
Drugs 2003, 4, 206-209.
(45) Young, S. L-870,810: A potent antiviral HIV integrase inhibitor with
potential clinical utility. Presented at the XIV International AIDS
Conference, West Point, PA, 2002.
(25) Grobler, J. A.; Stillmock, K.; Hu, B.; Witmer, M.; Felock, P.;
Espeseth, A. S.; Wolfe, A.; Egbertson, M.; Bourgeois, M.; Melamed,
J.; Wai, J. S.; Young, S.; Vacca, J.; Hazuda, D. J. Diketo acid inhibitor
mechanism and HIV-1 integrase: Implications for metal binding in
the active site of phosphotransferase enzymes. Proc. Natl. Acad. Sci.
U.S.A. 2002, 99, 6661-6666.
(46) Hazuda, D. J.; Young, S. D.; Guare, J. P.; Anthony, N. J.; Gomez,
R. P.; Wai, J. S.; Vacca, J. P.; Handt, L.; Motzel, S. L.; Klein, H. J.;
Dornadula, G.; Danovich, R. M.; Witmer, M. V.; Wilson, K. A. A.;
Tussey, L.; Schleif, W. A.; Gabryelski, L. S.; Jin, L.; Miller, M. D.;
Casimiro, D. R.; Emini, E. A.; Shiver, J. W. Integrase inhibitors and
cellular immunity suppress retroviral replication in rhesus macaques.
Science 2004, 305, 528-532.
(47) Witvrouw, M.; Van Maele, B.; Vercammen, J., Hantson, A.;
Engelborghs, Y.; De Clercq, E.; Pannecouque, Debyser, Z. Novel
inhibitors of HIV-1 integration. Curr. Drug. Metab. 2004, 5, 291-
304.
(26) Marchand, C.; Johnson, A. A.; Karki, R. G.; Pais, G. C.; Zhang, X.;
Cowansage, K.; Patel, T. A.; Nicklaus, M. C.; Burke, T. R., Jr.;
Pommier, Y. Metal-dependent inhibition of HIV-1 integrase by beta-
diketo acids and resistance of the soluble double-mutant (F185K/
C280S). Mol. Pharmacol. 2003, 64, 600-609.
(27) Long, Y. Q.; Jiang, X. H.; Dayam, R.; Sanchez, T.; Shoemaker, R.;
Sei, S.; Neamati, N. Rational design and synthesis of novel dimeric
diketoacid-containing inhibitors of HIV-1 integrase: Implication for
binding to two metal ions on the active site of integrase. J. Med.
Chem. 2004, 47, 2561-2573.
(48) Cowan, J. A. The Biological Chemistry of Magnesium; VCH: New
York, 1995; pp 1-23.
(28) Lins, R. D.; Adesokan, A.; Soares, T. A.; Briggs, J. M. Investigations
on human immunodeficiency virus type 1 integrase/DNA binding
interactions via molecular dynamics and electrostatics calculations.
Pharmacol. Ther. 2000, 85, 123-131.
(29) Neamati, N. Patented small molecule inhibitors of HIV-1 integrase:
a ten-year saga. Expert Opin. Ther. Pat. 2002, 12, 709-724.
(30) Dayam, R.; Neamati, N. Small-molecule HIV-1 integrase inhibi-
tors: the 2001-2002 update. Curr. Pharm. Des. 2003, 9, 1789-
1802.
(31) Gupta, S. P.; Nagappa, A. N. Design and development of integrase
inhibitors as anti-HIV agents. Curr. Med. Chem. 2003, 10, 1779-
1794.
(32) Maurin, C.; Bailly, F.; Cotelle, P. Structure-activity relationship of
HIV-1 integrase inhibitor-enzyme-ligand interaction. Curr. Med.
Chem. 2003, 10, 1795-1810.
(33) Johnson, A. A.; Marchand, C.; Pommier, Y. HIV-1 integrase
inhibitors: a decade of research and two drugs in clinical trial. Curr.
Top Med. Chem. 2004, 4, 671-686.
(34) Pais, G. C. G.; Burke, T. R. Novel aryl diketo-containing inhibitors
of HIV-1 integrase. Drugs Future 2002, 27, 1101-1111.
(35) Goldgur, Y.; Craigie, R.; Cohen, G. H.; Fujiwara, T.; Yoshinaga,
T.; Fujishita, T.; Sugimoto, H.; Endo, T.; Murai, H.; Davies, D. R.
Structure of the HIV-1 integrase catalytic domain complexed with
an inhibitor: a platform for antiviral drug design. Proc. Natl. Acad.
Sci. U.S.A. 1999, 96, 13040-13043.
(36) Hazuda, D. J.; Felock, P.; Witmer, M.; Wolfe, A.; Stillmock, K.;
Grobler, J. A.; Espeseth, A.; Gabryelski, L.; Schleif, W.; Blau, C.;
Miller, M. D. Inhibitors of strand transfer that prevent integration
and inhibit HIV-1 replication in cells. Science 2000, 287, 646-650.
(37) Wai, J. S.; Egbertson, M. S.; Payne, L. S.; Fisher, T. E.; Embrey,
M. W.; Tran, L. O.; Melamed, J. Y.; Langford, H. M.; Guare, J. P.,
Jr.; Zhuang, L.; Grey, V. E.; Vacca, J. P.; Holloway, M. K.; Naylor-
Olsen, A. M.; Hazuda, D. J.; Felock, P. J.; Wolfe, A. L.; Stillmock,
K. A.; Schleif, W. A.; Gabryelski, L. J.; Young, S. D. 4-Aryl-2,4-
dioxobutanoic acid inhibitors of HIV-1 integrase and viral replication
in cells. J. Med. Chem. 2000, 43, 4923-4926.
(49) Pemberton, I. K.; Buckle, M.; Buc, H. The metal ion-induced
cooperative binding of HIV-1 integrase to DNA exhibits a marked
preference for Mn(II) rather than Mg(II). J. Biol. Chem. 1996, 271,
1498-1506.
(50) Chen, I.-J. ; Neamati, N.; MacKerrel, A. D., Jr. Structure-based
inhibitor design targeting HIV-1 integrase. Curr. Drug Target Infect.
Dis. 2002, 2, 217-234.
(51) Hazuda, D. J.; Hastings, J. C.; Wolfe, A. L.; Emini, E. A. A novel
assay for the DNA strand-transfer reaction of HIV-1 integrase.
Nucleic Acids Res. 1994, 22, 1121-1122.
(52) Mazumder, A.; Neamati, N.; Sunder, S.; Owen, J.; Pommier, Y.
Retroviral integrase: A novel target in antiviral development; basic
in vitro assays with the purified enzyme. In Methods in Cellular and
Molecular Biology: AntiViral EValuation; Humana Press: Totowa,
NJ, 1999.
(53) Marchand, C.; Neamati, N.; Pommier, Y. In vitro human immuno-
deficiency virus type 1 integrase assays. Method Enzymol. 2001, 340,
624-633.
(54) Debyser, Z.; Cherepanov, P.; Pluymers, W.; De Clercq, E. Assays
for the evaluation of HIV-1 integrase inhibitors. Methods Mol. Biol.
2001, 160, 139-155.
(55) Tanaka, A.; Terasawa, T.; Hagihara, H., Sakuma, Y.; Ishibe, N.,
Sawada, M.; Takasugi, H.; Tanaka, H. Inhibitors of acyl-CoA:
cholesterol O-acyltransferase. 2. Identification and structure-activity
relationships of a novel series of N-alkyl-N-(heteroaryl-substituted
benzyl)-N′-arylureas. J. Med. Chem. 1998, 41, 2390-2410.
(56) Sechi, M.; Sannia, L.; Carta, F.; Palomba, M.; Dallocchio, R.; Dess`ı,
A.; Derudas, M.; Zawahir, Z.; Neamati, N. Design of novel
bioisosteres of â-diketoacid inhibitors of HIV-1 integrase. AntiViral
Chem. Chemother. 2005, 16, 41-61.
(57) Maurin, C.; Bailly, F.; Cotelle, P. Improved preparation and structural
investigation of 4-aryl-4-oxo-2-hydroxy-2-butenoic acids and methyl
esters. Tetrahedron 2004, 60, 6479-6486.
(58) Brecker, L.; Pogorevc, M.; Griengl, H., Steiner, W.; Kappe, T.;
Ribbons, D, W. Synthesis of 2,4-diketoacids and their aqueous
solution structures. New J. Chem. 1999, 23, 437-446.
(59) Rossotti, F. J. C.; Rossotti, H. The determination of stability constants
and other equilibrium constants in solution; McGraw-Hill: New
York, 1961; Chapt. 17.
(38) Pluymers, W.; Pais, G.; Van Maele, B.; Pannecouque, C.; Fikkert,
V.; Burke, T. R., Jr.; De Clercq, E.; Witvrouw, M.; Neamati, N.;
Debyser, Z. Inhibition of HIV-1 integration by diketo derivatives.
Antimicrob. Agents Chemother. 2002, 46, 3292-3297.